Business Context and Reporting Period
This Form 6-K filing by Rentokil Initial plc covers the month of May 2023, with a specific reporting date of May 12, 2023. The document serves as a notification of a transaction involving a person discharging managerial responsibilities (PDMR) in compliance with Article 19 of the EU Market Abuse Regulation (as retained in UK law).
Key Financial Metrics
The filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. It is strictly a disclosure of a specific share transaction.
| Metric | Value |
|---|---|
| Transaction Type | Purchase of American Depositary Shares (ADSs) |
| Volume | 375 ADSs |
| Price per ADS | US$40.12 |
| Total Transaction Value | US$15,045.00 |
| Transaction Date | May 10, 2023 |
| Exchange | New York Stock Exchange |
Material Changes
The filing reports a change in the shareholding of David Frear, a Non-Executive Director. He purchased 375 ADSs (equivalent to 1,875 ordinary shares) on May 10, 2023. No other material changes to the company's operations or financial position are disclosed in this document.
Guidance, Outlook, and Risks
The filing text does not provide any guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items. The document is limited to the statutory notification of the director's share purchase.
Key Facts for Investor Verification
- Insider Confidence: A Non-Executive Director purchased shares in the open market, which may be interpreted as a signal of confidence in the company's valuation.
- Transaction Scale: The purchase volume (375 ADSs) and total value (approx. US$15k) are relatively small, typical for routine director shareholding adjustments rather than a major strategic move.
- Regulatory Compliance: The transaction was executed on the NYSE and reported to the SEC to satisfy UK/EU Market Abuse Regulation requirements.
- Share Conversion: Investors should note that each ADS represents five ordinary shares of one pence each.